| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Submitted on December 12, 2005
Accepted on March 22, 2006
Department of Obstetrics and Gynecology, University of Leipzig, Germany (H.S., R.F.); Department of Physics, University of Potsdam, Germany (N.W.); Max-Delbrück Center for Molecular Medicine, Berlin, Germany (G.W.); Department of Cardiology and Pneumology, Charité - Campus Benjamin Franklin, Berlin, Germany (H.P.S., T.W.); Department of Pharmacology, Erasmus Medical Center, Rotterdam, The Netherlands (T.W.)
* To whom correspondence should be addressed. E-mail: thomas.walther{at}charite.de.
Context: Placental and circulatory soluble fms-like tyrosine kinase 1 (sFlt1) has proven to be elevated in pregnant women with preeclampsia, a disease characterized by hypertension, proteinuria and endothelial dysfunction. Recent studies have also demonstrated an autoantibody against the angiotensin AT1 receptor (AT1-AA) in that disease.
Objective: Both factors are discussed as key players in the etiology of preeclampsia. However, it has not yet been clarified whether these two circulating factors correlate and whether synergy determines the severity of pathology.
Design: AT1-AA was retrospectively determined by a bioassay and sFlt1 by an ELISA.
Patients: Serum from second trimester pregnancies with normal or abnormal uterine perfusion and in women at term with or without pregnancy pathology.
Results: Most of the preeclamptic patients were characterized by high sFlt1 levels and the presence of AT1-AA, though the agonistic effects of the antibody did not correlate with the sFlt1 concentrations (P = 0.85). While AT1-AA was also detected in second trimester pregnancies evidencing abnormal uterine perfusion without later pathology, sFlt1 was not significantly elevated in these pregnancies compared with those with normal uterine perfusion. However, while women with abnormal perfusion and later pregnancy pathology did not differ in AT1-AA compared with those with normal outcome, sFlt1 was significantly increased. Again, the two factors did not correlate (P = 0.15).
Conclusions: We conclude that AT1-AA bioactivity and sFlt1 concentrations do not correlate, are not mutually dependent, and are thus probably involved in distinct pathogenetic mechanisms. Both factors in combination may not be causative for the early impaired trophoblast invasion and pathological uterine perfusion.
This article has been cited by other articles:
 |
|
 |
|
  B. D. LaMarca, J. Gilbert, and J. P. Granger Recent Progress Toward the Understanding of the Pathophysiology of Hypertension During Preeclampsia Hypertension, April 1, 2008; 51(4): 982 - 988. [Full Text] [PDF]
|
|
|
|
|
|
C. C. Zhou, S. Ahmad, T. Mi, S. Abbasi, L. Xia, M.-C. Day, S. M. Ramin, A. Ahmed, R. E. Kellems, and Y. Xia Autoantibody From Women With Preeclampsia Induces Soluble Fms-Like Tyrosine Kinase-1 Production via Angiotensin Type 1 Receptor and Calcineurin/Nuclear Factor of Activated T-Cells Signaling Hypertension, April 1, 2008; 51(4): 1010 - 1019. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. S. Gilbert, M. J. Ryan, B. B. LaMarca, M. Sedeek, S. R. Murphy, and J. P. Granger Pathophysiology of hypertension during preeclampsia: linking placental ischemia with endothelial dysfunction Am J Physiol Heart Circ Physiol, February 1, 2008; 294(2): H541 - H550. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. S. Gilbert, S. A. Babcock, and J. P. Granger Hypertension Produced by Reduced Uterine Perfusion in Pregnant Rats Is Associated With Increased Soluble Fms-Like Tyrosine Kinase-1 Expression Hypertension, December 1, 2007; 50(6): 1142 - 1147. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |
